[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100588320":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":28,"locations":37,"responsibleParty":53,"collaborators":11,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":11,"eligibilityCriteria":61,"healthyVolunteers":62,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":11,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":75,"overallStatus":79,"whyStopped":11,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"Jacksonville University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Supplement Group","ACTIVE_COMPARATOR",null,[13],"Dietary Supplement: Shatavari Root Extract, oral capsule",{"label":15,"type":16,"description":11,"interventionNames":17},"Placebo Group: Sugar pill","PLACEBO_COMPARATOR",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":11},"DIETARY_SUPPLEMENT","Shatavari Root Extract, oral capsule","This intervention consists of a proprietary, standardized extract of Asparagus racemosus (Shatavari), formulated specifically for women's health and cognitive support. The supplement is provided in oral capsule form and standardized to a specific concentration of shatavarin IV, the primary active compound. Participants will take one capsule daily for 30 days.\n\nThis formulation, known as SheVari4™, is patent-pending and manufactured by Cepham, designed to address vasomotor symptoms (hot flashes) and other menopausal concerns. It is distinct from other Shatavari supplements in its standardization and use in a placebo-controlled, double-blind trial targeting postmenopausal women.",[15,9],[25],{"name":26,"affiliation":5,"role":27},"Heather A Hausenblas, PhD","PRINCIPAL_INVESTIGATOR",[29,33],{"name":26,"role":30,"phone":31,"phoneExt":11,"email":32},"CONTACT","904-891-9746","hhausen@ju.edu",{"name":34,"role":30,"phone":35,"phoneExt":11,"email":36},"Stephanie L Hooper, MPH","908-868-8740","s.hooper@unf.edu",[38],{"facility":5,"status":11,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Jacksonville","Florida","32211","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-81.65565,30.33218,{"lat":48,"lon":47},[51,52],{"name":26,"role":30,"phone":31,"phoneExt":11,"email":32},{"name":34,"role":30,"phone":35,"phoneExt":11,"email":36},{"type":54,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100588320","effect-of-a-cepham-supplement-on-hot-flashes-and-menopausal-symptoms-in-postmenopausal-women-100588320",false,"NCT06939868","Effect of a Cepham Supplement on Hot Flashes and Menopausal Symptoms in Postmenopausal Women","Effectiveness of 'Cepham Supplement' on Hot Flash Severity\u002FFrequency and Menopausal Symptoms in Postmenopausal Women: A Randomized Double-Blind Placebo-Controlled Trial","Inclusion Criteria:\n\n* Adult women aged 40-60 years.\n* Menopause Rating Scale score: (a) GE 14 and (b) score of 3 or 4 (severe to very severe) for hot flashes (Blumel et al., 2018).\n\nExclusion Criteria:\n\n* Current use of hormone therapy or other medications known to affect hot flashes.\n* Significant comorbidities that may interfere with study participation.",true,"FEMALE","40 Years","60 Years",{"count":67,"type":68},44,"ESTIMATED","INTERVENTIONAL",[71],"NA","The goal of this clinical trial is to learn if a daily nutritional supplement can reduce hot flashes and other menopausal symptoms in postmenopausal women.\n\nThe main questions this study aims to answer are:\n\nDoes the supplement reduce the number and severity of daily hot flashes?\n\nDoes it improve other common menopausal symptoms?\n\nResearchers will compare the supplement to a placebo (a look-alike capsule with no active ingredients) to see if it helps manage symptoms during menopause.\n\nParticipants will:\n\nTake either the supplement or a placebo daily for 30 days\n\nTrack their hot flashes each day using a short online survey\n\nComplete a symptom questionnaire at the beginning and end of the study\n\nThis study is for women ages 40-60 who have been postmenopausal for at least one year and currently experience bothersome hot flashes.",[74],"D008593",[76,77,78],"menopause","hot flashes","supplement","NOT_YET_RECRUITING","2025-04-18",{"date":82,"type":83},"2025-04-23","ACTUAL",{"date":85,"type":68},"2025-05-01",{"date":87,"type":68},"2025-09-30",{"name":5,"class":6},1]